to Commence Trading on the TSX on December 16, 2021 Numinus will ring the TSX opening bell to celebrate this milestone
VANCOUVER, BC, Dec. 14, 2021 /PRNewswire/ - Numinus Wellness Inc. ("Numinus" or the "Company") (TSXV: NUMI), a mental health care company advancing innovative treatments and safe, evidence-based psychedelic-assisted therapies, is pleased to announce that it has received final approval from the Toronto Stock Exchange ("TSX") to graduate its listing to the TSX from the TSX-Venture Exchange ("TSXV"). Numinus' common shares will commence trading on the TSX under the symbol "NUMI" at market open on Thursday, December 16, 2021. Similarly, the Company's listed warrants will commence trading on the TSX under the symbols "NUMI.WT", "NUMI.WT.B" and "NUMI.WT.C" on the same day.
No actions are required by Numinus shareholders. There will be no change to the shares, warrants or Company share structure as a result of this listing graduation. The TSX and TSXV have published bulletins announcing the change to financial institutions.
TSX Opening Bell Ringing
Numinus will celebrate this milestone by ringing the opening bell of the TSX on Thursday, December 16, 2021. Numinus Founder and CEO, Payton Nyquvest, will be joined by members of Numinus' senior management team at the event.
About Numinus
Numinus helps people to heal and be well through the development and delivery of innovative mental health care and access to safe, evidence-based psychedelic-assisted therapies. The Numinus model – including psychedelic production, research and clinic care – is at the forefront of a transformation aimed at healing rather than managing symptoms for depression, anxiety, trauma, pain and substance use. At Numinus, we are leading the integration of psychedelic-assisted therapies into mainstream clinical practice and building the foundation for a healthier society.
Learn more at www.numinus.com and follow us on LinkedIn, Facebook, Twitter, and Instagram.